Literature DB >> 34991404

Insurance payment for artificial intelligence technology: Methods used by a stroke artificial intelligence system and strategies to qualify for the new technology add-on payment.

Nick M Murray1, Phillip Phan2,3, Greg Hager4, Andrew Menard5, David Chin6, Alvin Liu7, Ferdinand K Hui5.   

Abstract

The first ever insurance reimbursement for an artificial intelligence (AI) system, which expedites triage of acute stroke, occurred in 2020 when the Centers for Medicare and Medicaid Services (CMS) granted approval for a New Technology Add-on Payment (NTAP). Key aspects of the AI system that led to its approval by the CMS included its unique mechanism of action, use of robotic process automation, and clear linkage of the system's output to clinical outcomes. The specific strategies employed encompass a first-case scenario of proving reimbursable value for improved stroke outcomes using AI. Given the rapid change in utilization of AI technology in stroke care, we describe the economic drivers of stroke AI systems in healthcare, focusing on concepts of reimbursement for value added by AI to the stroke care system. This report reviews (1) the successful approach used by the first NTAP-approved AI system, (2) economic variables in insurance reimbursement for AI, and (3) resultant strategies that may be utilized to facilitate qualification for NTAP reimbursement, which may be adopted by other AI systems used in stroke care.

Entities:  

Keywords:  Artificial intelligence; economics; neuroimaging; new technology add-on payment; stroke, insurance reimbursement

Mesh:

Year:  2022        PMID: 34991404      PMCID: PMC9244751          DOI: 10.1177/19714009211067408

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  19 in total

Review 1.  Evaluation of technologies approved for supplemental payments in the United States.

Authors:  Timothy J Judson; Sanket S Dhruva; Rita F Redberg
Journal:  BMJ       Date:  2019-06-17

2.  Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke.

Authors:  Wolfgang G Kunz; Myriam G Hunink; Mohammed A Almekhlafi; Bijoy K Menon; Jeffrey L Saver; Diederik W J Dippel; Charles B L M Majoie; Tudor G Jovin; Antoni Davalos; Serge Bracard; Francis Guillemin; Bruce C V Campbell; Peter J Mitchell; Philip White; Keith W Muir; Scott Brown; Andrew M Demchuk; Michael D Hill; Mayank Goyal
Journal:  Neurology       Date:  2020-09-17       Impact factor: 9.910

3.  Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke.

Authors:  Mattias Aronsson; Josefine Persson; Christian Blomstrand; Per Wester; Lars-Åke Levin
Journal:  Neurology       Date:  2016-02-12       Impact factor: 9.910

4.  Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review.

Authors:  Nick M Murray; Mathias Unberath; Gregory D Hager; Ferdinand K Hui
Journal:  J Neurointerv Surg       Date:  2019-10-08       Impact factor: 5.836

5.  Adoption and Trends in the Medicare New Technology Add-On Payment Program.

Authors:  Jacob R Morey; Margaret Katana; Lihua Li; Sam Hohmann; Ellerie Weber; Bart Ferket
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 6.473

Review 6.  Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries.

Authors:  Sara Gerke; Ariel D Stern; Timo Minssen
Journal:  NPJ Digit Med       Date:  2020-07-10

7.  Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices.

Authors:  Michael D Abràmoff; Philip T Lavin; Michele Birch; Nilay Shah; James C Folk
Journal:  NPJ Digit Med       Date:  2018-08-28

8.  New Technology Add-On Payment (NTAP) for Viz LVO: a win for stroke care.

Authors:  Ameer E Hassan
Journal:  J Neurointerv Surg       Date:  2020-11-24       Impact factor: 5.836

9.  The Changing Characteristics of Technologies Covered by Medicare's New Technology Add-on Payment Program.

Authors:  Christopher R Manz; Justin E Bekelman; Jalpa A Doshi
Journal:  JAMA Netw Open       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.